Form D · Private Equity Fund
TPG Biotech Equity IV, L.P.
Fort Worth, TX · CIK 0001611985
Offering snapshot reported Jul 10, 2014 · SEC filing
- Reported sold
- $2.5M Indefinite offering
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 30, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 10, 2014 | Initial | $2,500,000 | No comparison | 8 | SEC filing |
Offering details
- Securities
- Pooled investment fund, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-220777
Limited Partnership Interests
Source: Form D, filed Jul 10, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David Bonderman | Director, Executive |
| James G. Coulter | Director, Executive |
| None Tarrant Advisors, Inc. | Promoter |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
301 Commerce Street, Suite 3300
Fort Worth, TX, 76102
Fort Worth, TX, 76102